CSC
IBB icon

Caldwell Sutter Capital’s iShares Biotechnology ETF IBB Stock Holding History

Caldwell Sutter Capital’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$217K Hold
1,142
– – 0.08% 212
2026
Q1 		$193K Hold
1,142
– – 0.08% 227
2025
Q4 		$193K Hold
1,142
– – 0.08% 218
2025
Q3 		$165K Sell
1,142
-300
-21% -$41K 0.07% 232
2025
Q2 		$182K Hold
1,442
– – 0.08% 219
2025
Q1 		$184K Sell
1,442
-100
-6% -$13.6K 0.09% 209
2024
Q4 		$204K Sell
1,542
-375
-20% -$52.7K 0.09% 201
2024
Q3 		$279K Hold
1,917
– – 0.13% 158
2024
Q2 		$263K Hold
1,917
– – 0.13% 162
2024
Q1 		$263K Sell
1,917
-85
-4% -$11.6K 0.13% 161
2023
Q4 		$272K Sell
2,002
-349
-15% -$42.6K 0.14% 151
2023
Q3 		$288K Hold
2,351
– – 0.16% 140
2023
Q2 		$298K Buy
2,351
+1,001
+74% +$130K 0.16% 139
2023
Q1 		$174K Hold
1,350
– – 0.13% 140
2022
Q4 		$177K Buy
+1,350
New +$174K 0.16% 112

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Caldwell Sutter Capital's IBB Position: Q2 2026 in Review

Caldwell Sutter Capital held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 1,142 shares worth $217K. The position accounts for 0.08% of the portfolio, ranked #212.

Caldwell Sutter Capital first reported a position in IBB in Q4 2022 and has held it in 15 quarters since. The position peaked at $298K in Q2 2023. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Caldwell Sutter Capital held 1,142 shares of iShares Biotechnology ETF worth $217K as of Q2 2026.
  • Caldwell Sutter Capital left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up 0.08% of Caldwell Sutter Capital's portfolio in Q2 2026, its #212 holding.
  • Caldwell Sutter Capital first reported a position in iShares Biotechnology ETF in Q4 2022 and has held it in 15 quarters since.
  • Caldwell Sutter Capital's iShares Biotechnology ETF position peaked at $298K in Q2 2023.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Caldwell Sutter Capital's 13F filing for Q2 2026, filed 5 Aug 2026.